Allosteric and Dominant-Negative Effects in a p53 Core Heterotetramer.

Area of Science:

• Molecular Biology
• Biochemistry
• Cancer Research

Background:

• The tumor suppressor protein p53 (protein 53) is frequently mutated in cancer.
• Mutant and wild-type p53 (protein 53) coexist in early cancer development, forming heterotetramers.
• The R249S mutant p53 (protein 53) exhibits a dominant-negative effect on wild-type p53 (protein 53), but the mechanism is unclear.

Purpose of the Study:

• To investigate the molecular mechanisms by which the R249S mutation causes dominant-negative effects in the p53 (protein 53) heterotetramer.
• To elucidate the role of allosteric inhibition in mediating the dominant-negative effect.

Main Methods:

• All-atom molecular dynamics simulations were employed.
• Analysis of interfacial interactions within the p53 (protein 53) heterotetramer.

Main Results:

• The R249S mutation reorganizes interfacial interactions in the p53 (protein 53) heterotetramer via multiple allosteric pathways.
• Wild-type p53 (protein 53) subunits form more stable interactions with the R249S mutant subunit than with other wild-type subunits.
• These altered interactions are an adaptive response to the mutation's negative effects.

Conclusions:

• The R249S mutation induces dominant-negative effects by disrupting the structural integrity and function of the p53 (protein 53) heterotetramer.
• Allosteric pathways mediate the transmission of the mutation's effects throughout the protein.
• Understanding these mechanisms is crucial for developing targeted anticancer therapies.